Vista Investment Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Sell
56,395
-9,036
-14% -$236K 0.34% 73
2026
Q1
$1.84M Sell
65,431
-2,840
-4% -$75.6K 0.49% 64
2025
Q4
$1.7M Sell
68,271
-1,342
-2% -$33.8K 0.44% 70
2025
Q3
$1.77M Buy
69,613
+48,900
+236% +$1.21M 0.5% 59
2025
Q2
$502K Sell
20,713
-856
-4% -$20K 0.14% 105
2025
Q1
$547K Sell
21,569
-9
-0% -$236 0.17% 103
2024
Q4
$572K Sell
21,578
-48,220
-69% -$1.31M 0.18% 103
2024
Q3
$2.02M Sell
69,798
-7,254
-9% -$212K 0.65% 53
2024
Q2
$2.16M Sell
77,052
-2,180
-3% -$60K 0.72% 46
2024
Q1
$2.2M Buy
79,232
+4,015
+5% +$111K 0.75% 45
2023
Q4
$2.17M Buy
+75,217
New +$2.27M 0.79% 46

Other funds holding PFE

Vista Investment Partners's PFE Position: Q2 2026 in Review

Vista Investment Partners reduced its Pfizer (PFE) stake by 14% in Q2 2026, selling an estimated $236K and leaving 56,395 shares worth $1.36M. The position accounts for 0.34% of the portfolio, ranked #73.

Vista Investment Partners first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.2M in Q1 2024. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Vista Investment Partners held 56,395 shares of Pfizer worth $1.36M as of Q2 2026.
  • Vista Investment Partners sold 9,036 Pfizer shares in Q2 2026, an estimated $236K.
  • Pfizer made up 0.34% of Vista Investment Partners's portfolio in Q2 2026, its #73 holding.
  • Vista Investment Partners first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • Vista Investment Partners's Pfizer position peaked at $2.2M in Q1 2024.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Vista Investment Partners's 13F filing for Q2 2026, filed 9 Jul 2026.